Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-25-160176
Filing Date
2025-07-17
Accepted
2025-07-17 06:04:48
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d949051dsctota.htm SC TO-T/A 25477
2 EX-99.(A)(5)(I) d949051dex99a5i.htm EX-99.(A)(5)(I) 18324
3 GRAPHIC g949051dsp06.jpg GRAPHIC 1567
4 GRAPHIC g949051g0717054522415.jpg GRAPHIC 2601
  Complete submission text file 0001193125-25-160176.txt   51685
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Subject) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-88827 | Film No.: 251128763
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)